This week’s View offers key points to remember from an American Heart Association Scientific Statement on obstructive sleep apnea and cardiovascular disease, the Kidney Disease: Improving Global Outcomes 2021 clinical practice guideline for the management of blood pressure in patients with chronic kidney disease not receiving dialysis, and a state-of-the-art review on the genetics of adult-onset dilated cardiomyopathy.

This week’s View summarizes articles about the characteristics of patients with myocarditis temporally correlated with severe acute respiratory syndrome coronavirus 2 vaccination, differences in coronavirus disease 2019 hospital mortality rates between Black and White patients attributable to patient characteristics and hospital factors, and the validity of SCORE2 to estimate 10-year fatal and nonfatal cardiovascular disease risk in individuals in Europe without previous CVD or diabetes aged 40-69 years.

This week’s View summarizes articles about the prevalence and clinical significance of aortic branch aneurysms in patients with Marfan syndrome, whether triglyceride levels are associated with subclinical atherosclerosis and vascular inflammation regardless of low-density lipoprotein cholesterol, and the clinical outcomes associated with the use of 4-factor prothrombin complex concentrates, idarucizumab, or andexanet alpha for reversal of severe direct oral anticoagulant-associated bleeding.

This week’s View summarizes articles about how prevalent left atrial thrombus is in patients with atrial fibrillation or flutter who are on guideline-directed anticoagulation, the natural history of symptoms and ischemia in patients with ischemia with no obstructive coronary artery disease, and the characteristics and prognosis of patients with microvascular angina.

This week’s View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including articles on the effectiveness of same-day rapid antigen detection testing for severe acute respiratory syndrome coronavirus 2 for reducing the incidence of infection after social indoor gatherings; the safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents; and the prevalence of myocarditis in athletes with COVID-19 and screening strategies for safe return to play.

This week’s View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including articles on the incidence of venous thromboembolism and major bleeding in critically ill patients with COVID-19, the proportion of people with a positive severe acute respiratory syndrome coronavirus 2 test who are asymptomatic, and the safety and efficacy of high-titer convalescent plasma therapy in patients admitted to the hospital with COVID-19.

This week’s View highlights nine of the hottest trials presented at ACC.21: LAAOS III, ADAPTABLE, EXPLORER-HCM, FLOWER-MI, HOST-EXAM, DARE-19, REHAB-HF, FIDELIO-DKD, and GALACTIC-HF.

In this special episode of Eagle’s Eye View, Dr. Kim Eagle, Dr. Deepak Bhatt, and Dr. Payal Kohli discuss highlights from Day 3 of ACC.21, including SOLOIST and SCORED, LIFE, GALACTIC-HF, FIDELIO-DKD, and RESCUE.

In this special episode of Eagle’s Eye View, Dr. Kim Eagle, Dr. Deepak Bhatt, and Dr. Payal Kohli discuss highlights from Day 2 of ACC.21, including FLOWER-MI, DARE-19, COALITION ACTION, REHAB-HF, HOST-EXAM, and RADIANCE-HTN TRIO.

In this special episode of Eagle’s Eye View, Dr. Kim Eagle, Dr. Deepak Bhatt, and Dr. Payal Kohli discuss highlights from Day 1 of ACC.21, including LAAOS III, ATLANTIS, ADAPTABLE, EXPLORER-HCM, and PARADISE-MI.